Patents by Inventor Talia Miron

Talia Miron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100228037
    Abstract: A novel process of preparing allyl-containing asymmetric disulfides, and particularly therapeutically active allyl-containing asymmetric disulfides such as allylmercaptocaptopril (CPSSA) is disclosed.
    Type: Application
    Filed: January 24, 2007
    Publication date: September 9, 2010
    Applicant: Yeda Research And Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: Alexander Khenkin, Aharon Rabinkov, Talia Miron, Meir Wilchek, David Mirelman
  • Publication number: 20100069319
    Abstract: The invention provides novel mercaptopurine derivatives, e.g., S-allylthio-6-mercaptopurine and S-allylthio-6-mercaptopurine 9-riboside, as well as pharmaceutical compositions thereof. These compounds are highly efficient anti-proliferative agents, thus can be useful for treatment of various diseases or disorders, in particular, proliferative, inflammatory, skin and immune diseases or disorders.
    Type: Application
    Filed: March 2, 2008
    Publication date: March 18, 2010
    Inventors: Talia Miron, Aharon Rabinkov, David Mirelman, Meir Wilchek
  • Publication number: 20090209613
    Abstract: Use of allylmercaptocaptopril for treating or preventing obesity and/or an obesity related disease or disorder is disclosed.
    Type: Application
    Filed: June 13, 2006
    Publication date: August 20, 2009
    Applicant: Yeda Researc And Development Co. Ltd. at the Weizmann Institute of Science
    Inventors: David Mirelman, Aharon Rabinkov, Talia Miron, Meir Wilchek, Talma Rosenthal
  • Patent number: 7445802
    Abstract: Conjugates of the enzyme alliinase with a protein carrier that targets the alliinase to specific cells are used in combination with alliin to produce allicin at a desired target site. The enzyme converts alliin to allicin at the target site to kill cancer cells or pathogens.
    Type: Grant
    Filed: December 26, 2001
    Date of Patent: November 4, 2008
    Assignee: Yeda Research and Development Co. Ltd
    Inventors: Aharon Rabinkov, Talia Miron, David Mirelman, Meir Wilchek
  • Patent number: 7241902
    Abstract: Compounds which are the reaction product of allicin and ACE-inhibiting compounds are useful in treating hypertension, elevated triglycerides, and elevated insulin.
    Type: Grant
    Filed: May 30, 2002
    Date of Patent: July 10, 2007
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Talia Miron, Aharon Rabinkov, David Mirelman, Meir Wilchek
  • Publication number: 20060110472
    Abstract: The invention provides methods for: (a) protecting agricultural crops, particularly fruits and vegetables, against insects, by treating the crops with allicin prior to harvesting; (b) protecting fruits and vegetables from decay and extending the shelf life thereof by treating the fruits and vegetables with allicin after harvesting; and (c) repelling insects such as ants or insects that attack agricultural crops from an object or an area, which comprises treating the object or area with a repelling effective amount of allicin.
    Type: Application
    Filed: April 24, 2003
    Publication date: May 25, 2006
    Inventors: Talia Miron, Aharon Rabinkov, Meir Wilchek, David Mirelman, Talila Volk
  • Publication number: 20040210065
    Abstract: Compounds which are the reaction product of allicin and ACE-inhibiting compounds are useful in treating hypertension, elevated triglycerides, and elevated insulin.
    Type: Application
    Filed: June 2, 2004
    Publication date: October 21, 2004
    Inventors: Talia Miron, Aharon Rabinkov, David Mirelman, Meir Wilchek
  • Publication number: 20040115183
    Abstract: Conjugates of the enzyme alliinase with a protein carrier that targets the alliinase to specific cells are used in combination with alliin to produce allicin at a desired target site. The enzyme converts alliin to allicin at the target site to kill cancer cells or pathogens.
    Type: Application
    Filed: December 31, 2003
    Publication date: June 17, 2004
    Inventors: Aharon Rabinkov, Talia Miron, David Mirelman, Meir Wilchek
  • Publication number: 20040082479
    Abstract: Allicin is administered to soil prior to seeding or planting in order to protect the plants against pathogenic organisms, such as fungi, bacteria, protozoa and soil nematodes.
    Type: Application
    Filed: December 23, 2003
    Publication date: April 29, 2004
    Inventors: David Mirelman, Miriam Abramski, Ilan Chet, Talia Miron, Aharon Rabinkov, Meir Wilchek
  • Patent number: 6689588
    Abstract: Immobilized garlic alliinase wherein the alliinase is chemically, physically or biologically immobilized, is useful in a method for continuous production of allicin. The method comprises adding a solution of alliin as substrate to a column containing the immobilized garlic alliinase and collecting pure allicin in the effluent. The pure allicin is intended for use as food additive or for the preparation of pharmaceutical compositions for the treatment of viral, bacterial, fungal and parasitic infections, high levels of cholesterol and blood lipids, high blood pressure and thrombosis.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: February 10, 2004
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: David Mirelman, Meir Wilchek, Talia Miron, Aharon Rabinkov, Hephzibah Sivaraman